Vesicle-Based Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 March 2026 | Viewed by 4753
Special Issue Editors
Interests: drug delivey systems based on vesicles; lipid-based systems; surfactant-based systems; sensitive polymers
Special Issue Information
Dear Colleagues,
Ensuring safe and efficient drug delivery remains a critical challenge in pharmaceutical development. Recent advances in vesicle engineering, including liposomes, niosomes, exosomes, extracellular vesicles, and polymersomes, have significantly enhanced drug delivery strategies. These systems improve therapeutic efficacy by protecting active pharmaceutical ingredients (APIs) from degradation, minimizing side effects, enabling targeted delivery to disease sites, and controlling circulation time and release kinetics. Precise synthesis strategies for design can help to overcome biological barriers when applied through different administration routes, and remain key challenges that must be addressed to optimize treatment outcomes.
This Special Issue will highlight current advancements in vesicle-based platforms designed to improve formulation pharmacokinetics. We invite contributions that explore innovative approaches in vesicle design, drug loading, synthesis, isolation, targeting (both active and passive), and functionalization strategies to address these challenges in vesicle delivery.
Dr. Luciano Benedini
Prof. Dr. Paula Messina
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liposomes
- exosomes
- extracellular vesicles
- niosomes
- polymersomes
- active and passive targeting
- pharmacokinetics
- isolation/synthesis
- functionalization
- modified release
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
